Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 15, 2021 - Issue
Submit an article Journal homepage
128
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7

Ritsuko Kubota-Koketsu1 Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan;2 Surveillance Section, Research and Production Technology Department, The Research Foundation for Microbial Diseases of Osaka University, Kagawa, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0623-038X
ORCID Icon,
Mikihiro Yunoki3 Research and Development Division, Japan Blood Products Organization, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1548-5894
ORCID Icon,
Yoshinobu Okuno4 Kanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kagawa, Japan
&
Kazuyoshi Ikuta1 Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
Pages 87-94 | Published online: 13 Apr 2021

References

  • World Health Organization. Influenza at the human-animal interface. Summary and assessment; 2021. Available from: https://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment/en/. Accessed March 17, 2021.
  • Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis. 2006;12:9–14. doi:10.3201/eid1201.051254
  • Yunoki M, Kubota-Koketsu R, Urayama T, et al. Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1. Br J Haematol. 2010;148:953–955. doi:10.1111/j.1365-2141.2009.08016.x
  • Kubota-Koketsu R, Yunoki M, Okuno Y, Ikuta K. Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010. Biologics. 2012;6:245–247. doi:10.2147/BTT.S33495
  • Onodera H, Urayama T, Hirota K, et al. Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin. Biologics. 2017;11:23–30. doi:10.2147/BTT.S123831
  • Hohenadl C, Wodal W, Kerschbaum A, et al. Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice. Virol J. 2014;11:70. doi:10.1186/1743-422X-11-70
  • Kreil TR, Mc Vey JK, Lei LS, et al. Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza. Transfusion. 2012;52:803–809. doi:10.1111/j.1537-2995.2011.03347.x
  • Rockman S, Lowther S, Camuglia S, et al. Intravenous immunoglobulin protects against severe pandemic influenza infection. EBioMedicine. 2017;19:119–127. doi:10.1016/j.ebiom.2017.04.010
  • Pichyangkul S, Jongkaewwattana A, Thitithanyanont A, et al. Cross-reactive antibodies against avian influenza virus A (H5N1). Emerg Infect Dis. 2009;15:1537–1539. doi:10.3201/eid1509.090471
  • Sullivan JS, Selleck PW, Downton T, et al. Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture. J Mol Genet Med. 2009;3:217–224. doi:10.4172/1747-0862.1000038
  • Okuno Y, Tanaka K, Baba K, Maeda A, Kunita N, Ueda S. Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J Clin Microbiol. 1990;28:1308–1313. doi:10.1128/JCM.28.6.1308-1313.1990
  • Ohshima N, Kubota-Koketsu R, Iba Y, Okuno Y, Kurosawa Y. Two types of antibodies are induced by vaccination with A/California/2009 pdm virus: binding near the sialic acid-binding pocket and neutralizing both H1N1 and H5N1 viruses. PLoS One. 2014;9:e87305. doi:10.1371/journal.pone.0087305
  • Ohshima N, Iba Y, Kubota-Koketsu R, Asano Y, Okuno Y, Kurosawa Y. Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5. J Virol. 2011;85(21):11048–11057. doi:10.1128/JVI.05397-11
  • Centers for Disease Control and Prevention. Transmission of avian influenza A viruses between animals and people; 2015. Available from: https://www.cdc.gov/flu/avianflu/virus-transmission.htm#:~:text=Avian%20influenza%20A%20viruses%20may,host%2C%20such%20as%20a%20pig. Accessed March 17, 2021.
  • Takahashi T, Suzuki Y, Nishinaka D, et al. Duck and human pandemic influenza A viruses retain sialidase activity under low pH conditions. J Biochem. 2001;130:279–283. doi:10.1093/oxfordjournals.jbchem.a002983

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.